Soungalo T, Soumana D, Moussa S, François R
OCCGE/IPR 01 BP, Côte d'Ivoire.
Acta Trop. 1997 Dec;68(3):297-300. doi: 10.1016/s0001-706x(97)00103-4.
Ivermectin (Mectizan MK-933) is an efficient microfilaricidal drug used for mass treatment by the Onchocerciasis Control Programme (OCP) in the savanna zones of West Africa. Some populations of the forest zone of Côte d'Ivoire have very high microfilarial loads, so it was decided to treat some of these populations with ivermectin, in order to avoid an eventual reinfestation of the protected savanna areas. A pilot campaign was carried out in a small stream catchment area where onchocerciasis transmission is usually high. The whole population was treated orally with ivermectin (200 micrograms/kg of body weight), with the exception of children under 5 years of age, pregnant women and people who were ill. The results showed a very high efficiency of ivermectin in the treatment of onchocerciasis in the forest zone. The prevalence rate of microfilaria dropped from 60.1 to 33.2%. The community microfilarial load was reduced from 29.7 to 5.6 microfilariae per skin snip. To maintain this effect, the authors recommend regular treatment of all new comers into the area.
伊维菌素(美迪善,MK - 933)是一种高效的杀微丝蚴药物,用于西非稀树草原地区盘尾丝虫病控制计划(OCP)的群体治疗。科特迪瓦森林地区的一些人群微丝蚴负荷量非常高,因此决定对其中一些人群使用伊维菌素进行治疗,以避免受保护的稀树草原地区最终再次受到感染。在一个盘尾丝虫病传播通常很高的小流域集水区开展了一项试点活动。除5岁以下儿童、孕妇和患病者外,全体居民口服伊维菌素(200微克/千克体重)。结果显示,伊维菌素对森林地区盘尾丝虫病的治疗效果非常显著。微丝蚴患病率从60.1%降至33.2%。每处皮肤切片的群体微丝蚴负荷量从29.7条降至5.6条。为维持这一效果,作者建议对该地区所有新迁入者进行定期治疗。